|Lee, Paul, Kwan, Alan Shu Khen and Nokes, Leonard Derek Martin 2011. Actovegin® cutting-edge sports medicine or "Voodoo" remedy? Current Sports Medicine Reports 10 (4) , pp. 186-190. 10.1249/JSR.0b013e318223cd8a|
Actovegin® is a deproteinized serum extract of bovine origin, and in recent years it has been used widely in treating sport injuries with many anecdotal reports of success. However, the use of Actovegin® in sport medicine has caused a substantial amount of controversy, especially concerning its supposed oxygen-enhancing capacity and an anecdotal belief that its use can increase an athlete's performance. In 2009, a sports physician was arrested with this "performance-enhancing drug," while an editorial in a sports medicine journal strongly questioned the evidence base for using this drug for acute muscle injury. There is also a report that suggested that Actovegin® might have induced anaphylactic shock in a cyclist. In this review, we have systematically examined the current evidence on Actovegin®. Its mechanism of action, clinical evidence, legal status with sports governing bodies, and its potential role in sport injuries will be discussed. Copyright © 2011 by the American College of Sports Medicine.
|Subjects:||R Medicine > RM Therapeutics. Pharmacology|
|Uncontrolled Keywords:||EMTREE drug terms: actovegin; placebo EMTREE medical terms: anaphylactic shock; anaphylaxis; article; athletic performance; diabetic neuropathy; doping; drug mechanism; drug megadose; drug safety; fracture; human; medicolegal aspect; molecular mechanics; mouth ulcer; muscle injury; non insulin dependent diabetes mellitus; postpartum hemorrhage; skin ulcer; sport injury; sports medicine|
|Publisher:||Lippincott Williams & Wilkins|
|Last Modified:||12 Feb 2016 22:22|
Cited 3 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)